acetaminophen has been researched along with ranitidine in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (15.79) | 18.7374 |
1990's | 4 (7.02) | 18.2507 |
2000's | 21 (36.84) | 29.6817 |
2010's | 22 (38.60) | 24.3611 |
2020's | 1 (1.75) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Akamatsu, M | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fox, MJ; Frank, WO; Nambi, P; Palmer, RH; Wetherington, JD | 1 |
Barone, M; Bell, S; Demetris, J; Guglielmi, FW; Makowka, L; Panella, C; Polimeno, L; Prelich, JG; Rizzi, S; Van Thiel, DH | 1 |
Jack, D; Skidmore, IF; Thomas, M | 1 |
Dent, JG; Gale, KC; Leonard, TB; Newton, JF; Rogers, SA | 1 |
Hazama, H; Murase, T; Okuno, H; Sameshima, Y; Shiozaki, Y | 1 |
Greenblatt, DJ; Harmatz, JS; Matlis, R; Scavone, JM | 1 |
Chenery, RJ; Emery, S; Norman, SJ; Oldham, HG | 1 |
Bredfeldt, JE; von Huene, C | 1 |
Dent, JG; Leonard, TB | 1 |
Christian, DC; Mitchell, MC; Speeg, KV | 1 |
Davies, MH; Elias, E; Ngong, JM; Pean, A; Vickers, CR; Waring, RH | 1 |
Leach, IH; Robinson, MH; Wheatley, T | 1 |
Han, J; He, P; Li, XD; Lv, Y; Wu, MC; Xia, SQ | 1 |
Cadeddu, JA; Duchene, D; Johnson, DB; Recart, A; Thomas, T; White, PF | 1 |
Ando, M; Hiroshige, S; Kumamoto, T; Matsuno, O; Miyazaki, E; Nureki, S; Okubo, T; Ono, E; Takenaka, R; Ueno, T | 1 |
Dore, E; Maher, O; Nieto, JE; Snyder, JR; Stanley, SD | 1 |
Budha, NR; Christensen, ML; Mehrotra, N; Meibohm, B; Zhang, Y | 1 |
Brazelton, T; Hsu, B | 1 |
Bithell, EG; Eddleston, MD; Jones, W | 1 |
Belton, P; Bouman, J; de Vries, R; Qi, S; van der Linden, E; Venema, P | 1 |
Bartoli, F; Blagojevic, J; Bruni, C; Cometi, L; Fiori, G; Furst, DE; Galluccio, F; Matucci Cerinic, M; Tofani, L | 1 |
Alam, K; Devkota, R; Khan, GM; Regmi, A; Sapkota, B | 1 |
Goda, K; Kobayashi, A; Kuno, H; Shoda, T; Sugai, S; Takahashi, T | 1 |
Arndt, N; Cipriani, VP; Conte, WL; Dellaria, A; Javed, A | 1 |
Aryal, B; Paudel, S | 1 |
2 review(s) available for acetaminophen and ranitidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Nonsteroidal antiinflammatory drug-induced colonic stricture. An unusual cause of large bowel obstruction and perforation.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colon; Colonic Diseases; Delayed-Action Preparations; Dextropropoxyphene; Diclofenac; Drug Combinations; Drug Therapy, Combination; Emergencies; Female; Humans; Intestinal Obstruction; Intestinal Perforation; Middle Aged; Ranitidine | 1995 |
2 trial(s) available for acetaminophen and ranitidine
Article | Year |
---|---|
Ranitidine and paracetamol metabolism.
Topics: Acetaminophen; Animals; Clinical Trials as Topic; Double-Blind Method; Humans; Liver; Male; Random Allocation; Ranitidine; Rats | 1985 |
Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy.
Topics: Acetaminophen; Adult; Aged; Analgesics; Antiemetics; Cyclooxygenase 2 Inhibitors; Female; Histamine H2 Antagonists; Humans; Kidney Neoplasms; Lactones; Laparoscopy; Length of Stay; Male; Middle Aged; Nephrectomy; Pain, Postoperative; Postoperative Care; Postoperative Nausea and Vomiting; Preoperative Care; Ranitidine; Sulfones | 2005 |
53 other study(ies) available for acetaminophen and ranitidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol.
Topics: Acetaminophen; Adult; Alcohol Dehydrogenase; Animals; Cimetidine; Ethacrynic Acid; Ethanol; Female; Histamine H2 Antagonists; Humans; In Vitro Techniques; Male; Middle Aged; Nizatidine; Propranolol; Ranitidine; Rats; Reference Values; Salicylates; Salicylic Acid | 1991 |
Effect of ranitidine on acetaminophen-induced hepatotoxicity in dogs.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Male; Ranitidine | 1990 |
H2 receptor antagonists, cytochrome P450, and paracetamol-induced hepatotoxicity.
Topics: Acetaminophen; Animals; Cimetidine; Cytochrome P-450 Enzyme System; Humans; Liver; Mice; Ranitidine; Rats | 1985 |
Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine potentiation of acetaminophen-induced hepatotoxicity.
Topics: Acetaminophen; Alanine Transaminase; Animals; Cimetidine; Drug Synergism; Glucuronates; Glucuronosyltransferase; Liver; Male; Ranitidine; Rats; Rats, Inbred F344 | 1988 |
Effect of H2-receptor antagonists on acetaminophen-induced hepatic injury.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cimetidine; Famotidine; Glutathione; Liver; Liver Diseases; Male; Methylcholanthrene; Microsomes, Liver; Ranitidine; Rats; Thiazoles | 1986 |
Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.
Topics: Acetaminophen; Administration, Oral; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cimetidine; Drug Interactions; Drug Therapy, Combination; Humans; Kinetics; Male; Middle Aged; Oxaprozin; Propionates; Ranitidine; Regression Analysis | 1986 |
The effect of cimetidine and ranitidine on paracetamol glucuronidation and sulphation in cultured rat hepatocytes.
Topics: Acetaminophen; Animals; Cell Survival; Cells, Cultured; Cimetidine; Glucuronates; Glutathione; Liver; Male; Ranitidine; Rats; Rats, Inbred Strains; Sulfates | 1985 |
Ranitidine, acetaminophen, and hepatotoxicity.
Topics: Acetaminophen; Adult; Chemical and Drug Induced Liver Injury; Humans; Male; Ranitidine | 1984 |
Effects of H2 receptor antagonists on the hepatotoxicity of various chemicals.
Topics: 1-Propanol; Acetaminophen; Animals; Bromobenzenes; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chloroform; Cimetidine; Drug Antagonism; Drug Synergism; Histamine H2 Antagonists; Imidazoles; Liver; Male; Propanols; Pyrimidinones; Ranitidine; Rats; Rats, Inbred F344 | 1984 |
Ranitidine and acetaminophen hepatotoxicity.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Ranitidine; Rats | 1984 |
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
Topics: Acetaminophen; Adult; Carbocysteine; Case-Control Studies; Cysteine; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Oxidation-Reduction; Ranitidine; Reference Values; Sulfoxides; Sulfuric Acid Esters | 1995 |
Conjugation metabolism of acetaminophen and bilirubin in extrahepatic tissues of rats.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Bilirubin; Biotransformation; Chromatography, High Pressure Liquid; Glucuronides; Histamine H2 Antagonists; Hypnotics and Sedatives; Liver Function Tests; Phenobarbital; Ranitidine; Rats; Rats, Sprague-Dawley; Sulfates | 2004 |
Drug-induced lymphocyte stimulation test is not useful for the diagnosis of drug-induced pneumonia.
Topics: Acetaminophen; Adult; Aged, 80 and over; Analgesics, Non-Narcotic; Bronchial Provocation Tests; Drug Hypersensitivity; False Positive Reactions; Female; Histamine H2 Antagonists; Humans; Immunologic Tests; Lymphocyte Activation; Male; Middle Aged; Patch Tests; Pneumonia; Ranitidine | 2007 |
Evaluation of the effect of ranitidine on gastroduodenal contractile activity and gastric emptying in horses.
Topics: Acetaminophen; Animals; Anti-Ulcer Agents; Duodenum; Gastric Emptying; Horses; Male; Muscle Contraction; Ranitidine | 2008 |
A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens.
Topics: Acetaminophen; Analgesics; Anticonvulsants; Bronchodilator Agents; Caffeine; Calibration; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Histamine H2 Antagonists; Humans; Infant, Newborn; Phenytoin; Quality Control; Ranitidine; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Theophylline | 2008 |
Off-label medication use in an academic hospital pediatric critical care unit.
Topics: Academic Medical Centers; Acetaminophen; Adolescent; Child; Child, Preschool; Female; Fentanyl; Humans; Infant; Infant, Newborn; Intensive Care Units; Male; Morphine; Off-Label Use; Practice Patterns, Physicians'; Propofol; Ranitidine; Wisconsin | 2009 |
Transmission electron microscopy of pharmaceutical materials.
Topics: Acetaminophen; Caffeine; Crystallization; Microscopy, Electron, Transmission; Oxalic Acid; Pharmaceutical Preparations; Ranitidine; Theophylline | 2010 |
Controlled Release from Zein Matrices: Interplay of Drug Hydrophobicity and pH.
Topics: Acetaminophen; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Indomethacin; Kinetics; Ranitidine; Static Electricity; Tablets; Zein | 2016 |
Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
Topics: Acetaminophen; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chlorpheniramine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Female; Humans; Hydrocortisone; Hydroxyzine; Infliximab; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Premedication; Ranitidine; Retrospective Studies; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Medication utilization pattern for management of pregnancy complications: a study in Western Nepal.
Topics: Acetaminophen; Adult; Anti-Infective Agents; Butylscopolammonium Bromide; Cross-Sectional Studies; Drug Prescriptions; Female; Hospitals, Teaching; Humans; Nepal; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Ranitidine | 2016 |
Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
Topics: Acetaminophen; Apoptosis; Biological Assay; Biomarkers; Caspase 3; Caspase 7; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromans; Diclofenac; Dose-Response Relationship, Drug; Ethanol; Hepatocytes; Humans; Isoxazoles; Leflunomide; Liver; Mitochondria, Liver; Oxygen Consumption; Primary Cell Culture; Ranitidine; Risk Assessment; Thiazolidinediones; Time Factors; Toxicity Tests; Troglitazone | 2016 |
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol.
Topics: Acetaminophen; Administration, Intravenous; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Body Mass Index; Cetirizine; Diphenhydramine; Female; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Premedication; Ranitidine; Sex Factors; Treatment Outcome; Young Adult | 2019 |
Exploration of self-medication practice in Pokhara valley of Nepal.
Topics: Acetaminophen; Adult; Analgesics; Anti-Bacterial Agents; Common Cold; Cough; Cross-Sectional Studies; Female; Fluid Therapy; Humans; Male; Middle Aged; Nepal; Pain; Pharmaceutical Services; Ranitidine; Referral and Consultation; Self Medication; Surveys and Questionnaires | 2020 |